Penobscot Investment Management Company Inc. Lowers Stock Holdings in Agilent Technologies, Inc. $A

Key Points

• Penobscot Investment Management Company Inc. has reduced its stake in Agilent Technologies by 9.7%, owning 20,875 shares after selling 2,240 shares in the second quarter.
• Agilent Technologies reported earnings of $1.37 per share for the last quarter, meeting expectations, with a revenue increase of 10.1% year-over-year.
• The company has announced a quarterly dividend of $0.248 per share, with an ex-dividend date set for September 30th, offering an annual yield of 0.7%.

Penobscot Investment Management Company Inc. decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 9.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,875 shares of the medical research company's stock after selling 2,240 shares during the period. Penobscot Investment Management Company Inc.'s holdings in Agilent Technologies were worth $2,463,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of A. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the first quarter worth about $30,000. Opal Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the first quarter worth about $31,000. Ransom Advisory Ltd purchased a new position in shares of Agilent Technologies in the first quarter worth about $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the second quarter worth about $33,000. Finally, Zions Bancorporation National Association UT purchased a new position in shares of Agilent Technologies in the first quarter worth about $38,000.

Agilent Technologies Stock Up 2.3%

NYSE A opened at $141.91 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market capitalization of $40.23 billion, a PE ratio of 33.31, a PEG ratio of 4.53 and a beta of 1.26. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The business's 50-day moving average is $122.80 and its 200 day moving average is $116.41.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's payout ratio is presently 23.24%.

Analysts Set New Price Targets

Several research analysts have recently commented on A shares. Wells Fargo & Company lifted their price objective on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a report on Monday, September 15th. Evercore ISI decreased their price objective on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a report on Thursday, August 28th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Friday. Weiss Ratings reiterated a "hold (c)" rating on shares of Agilent Technologies in a report on Saturday, September 27th. Finally, Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a report on Thursday, August 28th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of "Hold" and an average target price of $142.17.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.